• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

同时存在的结构和生物物理特性与免疫球蛋白轻链淀粉样倾向相关联。

Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity.

机构信息

Dipartimento di Bioscienze, Università degli Studi di Milano, 20133, Milano, Italy.

Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, and Department of Molecular Medicine, University of Pavia, 27100, Pavia, Italy.

出版信息

Sci Rep. 2017 Dec 1;7(1):16809. doi: 10.1038/s41598-017-16953-7.

DOI:10.1038/s41598-017-16953-7
PMID:29196671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5711917/
Abstract

Light chain amyloidosis (AL), the most common systemic amyloidosis, is caused by the overproduction and the aggregation of monoclonal immunoglobulin light chains (LC) in target organs. Due to genetic rearrangement and somatic hypermutation, virtually, each AL patient presents a different amyloidogenic LC. Because of such complexity, the fine molecular determinants of LC aggregation propensity and proteotoxicity are, to date, unclear; significantly, their decoding requires investigating large sets of cases. Aiming to achieve generalizable observations, we systematically characterised a pool of thirteen sequence-diverse full length LCs. Eight amyloidogenic LCs were selected as responsible for severe cardiac symptoms in patients; five non-amyloidogenic LCs were isolated from patients affected by multiple myeloma. Our comprehensive approach (consisting of spectroscopic techniques, limited proteolysis, and X-ray crystallography) shows that low fold stability and high protein dynamics correlate with amyloidogenic LCs, while hydrophobicity, structural rearrangements and nature of the LC dimeric association interface (as observed in seven crystal structures here presented) do not appear to play a significant role in defining amyloid propensity. Based on the structural and biophysical data, our results highlight shared properties driving LC amyloid propensity, and these data will be instrumental for the design of synthetic inhibitors of LC aggregation.

摘要

轻链淀粉样变性(AL)是最常见的系统性淀粉样变性,由单克隆免疫球蛋白轻链(LC)在靶器官中的过度产生和聚集引起。由于遗传重排和体细胞超突变,实际上每个 AL 患者都存在不同的淀粉样变性 LC。由于这种复杂性,LC 聚集倾向和蛋白毒性的精细分子决定因素尚不清楚;重要的是,它们的解码需要研究大量的病例。为了实现可推广的观察结果,我们系统地描述了一组 13 种序列多样的全长 LC。选择了 8 种淀粉样变性 LC,它们是导致患者严重心脏症状的原因;从多发性骨髓瘤患者中分离出 5 种非淀粉样变性 LC。我们的综合方法(包括光谱技术、有限蛋白水解和 X 射线晶体学)表明,低折叠稳定性和高蛋白质动力学与淀粉样变性 LC 相关,而疏水性、结构重排和 LC 二聚体结合界面的性质(如这里呈现的七个晶体结构中观察到的)似乎在定义淀粉样倾向方面没有起到重要作用。基于结构和生物物理数据,我们的结果突出了驱动 LC 淀粉样倾向的共同特性,这些数据将对 LC 聚集的合成抑制剂的设计具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/5ff8c02d93e8/41598_2017_16953_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/0214b423d767/41598_2017_16953_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/f053f08f9322/41598_2017_16953_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/c3634b5f6d93/41598_2017_16953_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/5ff8c02d93e8/41598_2017_16953_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/0214b423d767/41598_2017_16953_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/f053f08f9322/41598_2017_16953_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/c3634b5f6d93/41598_2017_16953_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9588/5711917/5ff8c02d93e8/41598_2017_16953_Fig4_HTML.jpg

相似文献

1
Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity.同时存在的结构和生物物理特性与免疫球蛋白轻链淀粉样倾向相关联。
Sci Rep. 2017 Dec 1;7(1):16809. doi: 10.1038/s41598-017-16953-7.
2
Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.合成原纤维对患者来源的淀粉样生成蛋白和骨髓瘤轻链蛋白的差异募集效力——一种预测淀粉样蛋白倾向的指标
PLoS One. 2017 Mar 28;12(3):e0174152. doi: 10.1371/journal.pone.0174152. eCollection 2017.
3
The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.全长抗体轻链二聚体的动力学稳定性决定了内蛋白水解是否能释放出具有淀粉样变性的可变结构域。
J Mol Biol. 2016 Oct 23;428(21):4280-4297. doi: 10.1016/j.jmb.2016.08.021. Epub 2016 Aug 26.
4
Inherent Biophysical Properties Modulate the Toxicity of Soluble Amyloidogenic Light Chains.固有生物物理特性调节可溶性淀粉样轻链的毒性。
J Mol Biol. 2020 Feb 14;432(4):845-860. doi: 10.1016/j.jmb.2019.12.015. Epub 2019 Dec 24.
5
Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells.心脏淀粉样变中的蛋白毒性:淀粉样变轻链影响人心脏细胞内的蛋白质水平。
Sci Rep. 2017 Nov 15;7(1):15661. doi: 10.1038/s41598-017-15424-3.
6
Recruitment of human light chain proteins by synthetic fibrils is dependent on disease state and may be used to predict amyloidogenic propensity.合成原纤维对人轻链蛋白的募集取决于疾病状态,可用于预测淀粉样蛋白生成倾向。
Amyloid. 2017 Mar;24(sup1):24-25. doi: 10.1080/13506129.2017.1295374.
7
An N-glycosylation hotspot in immunoglobulin κ light chains is associated with AL amyloidosis.免疫球蛋白 κ 轻链中的 N-糖基化热点与 AL 淀粉样变性有关。
Leukemia. 2022 Aug;36(8):2076-2085. doi: 10.1038/s41375-022-01599-w. Epub 2022 May 24.
8
Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.心脏轻链淀粉样变中轻链片段化位点的质谱分析:对蛋白水解时间的深入了解。
J Biol Chem. 2020 Dec 4;295(49):16572-16584. doi: 10.1074/jbc.RA120.013461. Epub 2020 Sep 20.
9
A constant domain mutation in a patient-derived antibody light chain reveals principles of AL amyloidosis.患者源性抗体轻链中的恒定域突变揭示了 AL 淀粉样变性的原理。
Commun Biol. 2023 Feb 23;6(1):209. doi: 10.1038/s42003-023-04574-y.
10
In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.人淀粉样变免疫球蛋白轻链和重链蛋白的体外共表达:一种相关的基于细胞的AL淀粉样变性模型。
Amyloid. 2017 Jun;24(2):115-122. doi: 10.1080/13506129.2017.1336996. Epub 2017 Jun 20.

引用本文的文献

1
Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.多个位置上的克隆特异性残基变化与抗体轻链的淀粉样蛋白形成有关。
Front Immunol. 2025 Aug 1;16:1622207. doi: 10.3389/fimmu.2025.1622207. eCollection 2025.
2
B Cell-Derived and Non-B Cell-Derived Free Light Chains: From Generation to Biological and Pathophysiological Roles.B细胞衍生和非B细胞衍生的游离轻链:从产生到生物学及病理生理学作用
Int J Mol Sci. 2025 Aug 6;26(15):7607. doi: 10.3390/ijms26157607.
3
Investigating Local Sequence-Structural Attributes of Amyloidogenic Light Chain Variable Domains.

本文引用的文献

1
Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience.局限性免疫球蛋白轻链淀粉样变性的临床表现与预后:梅奥诊所经验
Mayo Clin Proc. 2017 Jun;92(6):908-917. doi: 10.1016/j.mayocp.2017.02.016. Epub 2017 May 5.
2
Aggregation of Full-length Immunoglobulin Light Chains from Systemic Light Chain Amyloidosis (AL) Patients Is Remodeled by Epigallocatechin-3-gallate.表没食子儿茶素-3-没食子酸酯重塑系统性轻链淀粉样变性(AL)患者全长免疫球蛋白轻链的聚集。
J Biol Chem. 2017 Feb 10;292(6):2328-2344. doi: 10.1074/jbc.M116.750323. Epub 2016 Dec 28.
3
The Kinetic Stability of a Full-Length Antibody Light Chain Dimer Determines whether Endoproteolysis Can Release Amyloidogenic Variable Domains.
研究淀粉样轻链可变结构域的局部序列-结构属性
Proteins. 2025 Mar 4. doi: 10.1002/prot.26815.
4
A conformational fingerprint for amyloidogenic light chains.淀粉样轻链的构象指纹图谱。
Elife. 2025 Mar 3;13:RP102002. doi: 10.7554/eLife.102002.
5
Conformational Differences in the Light Chain Constant Domain of Immunoglobulin G and Free Light Chain May Influence Proteolysis in AL Amyloidosis.免疫球蛋白 G 轻链恒定区和游离轻链构象的差异可能影响 AL 淀粉样变性中的蛋白水解。
J Mol Biol. 2024 Dec 1;436(23):168837. doi: 10.1016/j.jmb.2024.168837. Epub 2024 Oct 28.
6
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis.在一位淀粉样变性病患者的心脏原纤维中,淀粉样蛋白和胶原之间的螺旋超结构。
Nat Commun. 2024 Jul 28;15(1):6359. doi: 10.1038/s41467-024-50686-2.
7
Structural, Biophysical, and Computational Studies of a Murine Light Chain Dimer.结构、生物物理和计算研究的鼠轻链二聚体。
Molecules. 2024 Jun 18;29(12):2885. doi: 10.3390/molecules29122885.
8
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.轻链突变有助于确定系统性 AL 淀粉样变性中的纤维形态。
Nat Commun. 2024 Jun 15;15(1):5121. doi: 10.1038/s41467-024-49520-6.
9
Case report: Light-chain amyloidosis responsive to selinexor in combination with daratumumab and dexamethasone (SDd) therapy.病例报告:轻链淀粉样变性对塞利尼索联合达雷妥尤单抗及地塞米松(SDd)治疗有反应。
Front Med (Lausanne). 2024 May 2;11:1363805. doi: 10.3389/fmed.2024.1363805. eCollection 2024.
10
Biophysical characterization of human-cell-expressed, full-length κI O18/O8, AL-09, λ6a, and Wil immunoglobulin light chains.人细胞表达的全长 κI O18/O8、AL-09、λ6a 和 Wil 免疫球蛋白轻链的生物物理特性分析。
Biochim Biophys Acta Proteins Proteom. 2024 May 1;1872(3):140993. doi: 10.1016/j.bbapap.2023.140993. Epub 2023 Dec 31.
全长抗体轻链二聚体的动力学稳定性决定了内蛋白水解是否能释放出具有淀粉样变性的可变结构域。
J Mol Biol. 2016 Oct 23;428(21):4280-4297. doi: 10.1016/j.jmb.2016.08.021. Epub 2016 Aug 26.
4
Cell Damage in Light Chain Amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING.轻链淀粉样变性中的细胞损伤:原纤维内化、毒性及细胞介导的种子生成
J Biol Chem. 2016 Sep 16;291(38):19813-25. doi: 10.1074/jbc.M116.736736. Epub 2016 Jul 26.
5
Inhibition by small-molecule ligands of formation of amyloid fibrils of an immunoglobulin light chain variable domain.小分子配体对免疫球蛋白轻链可变区淀粉样原纤维形成的抑制作用。
Elife. 2015 Nov 18;4:e10935. doi: 10.7554/eLife.10935.
6
Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.突变可导致轻链过于稳定或过于不稳定而无法形成淀粉样纤维。
Protein Sci. 2015 Nov;24(11):1829-40. doi: 10.1002/pro.2790. Epub 2015 Sep 7.
7
Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding.使用依赖扫描速率的热解折叠对全长免疫球蛋白轻链AL-09及其种系蛋白进行热力学和原纤维形成研究。
Biophys Chem. 2015 Dec;207:13-20. doi: 10.1016/j.bpc.2015.07.005. Epub 2015 Aug 4.
8
Inhibition of Light Chain 6aJL2-R24G Amyloid Fiber Formation Associated with Light Chain Amyloidosis.与轻链淀粉样变性相关的轻链6a JL2-R24G淀粉样纤维形成的抑制作用。
Biochemistry. 2015 Aug 18;54(32):4978-86. doi: 10.1021/acs.biochem.5b00288. Epub 2015 Aug 6.
9
Proteomic detection of immunoglobulin light chain variable region peptides from amyloidosis patient biopsies.从淀粉样变性患者活检组织中进行免疫球蛋白轻链可变区肽段的蛋白质组学检测。
J Proteome Res. 2015 Apr 3;14(4):1957-67. doi: 10.1021/acs.jproteome.5b00015. Epub 2015 Mar 20.
10
Site-directed mutagenesis reveals regions implicated in the stability and fiber formation of human λ3r light chains.定点诱变揭示了与人类λ3r轻链的稳定性和纤维形成相关的区域。
J Biol Chem. 2015 Jan 30;290(5):2577-92. doi: 10.1074/jbc.M114.629550. Epub 2014 Dec 11.